Astellas Pharma, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 17.12% vs 10.78% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -41.76% vs 325.06% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "537,925.00",
          "val2": "459,294.00",
          "chgp": "17.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "128,212.00",
          "val2": "110,013.00",
          "chgp": "16.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3,035.00",
          "val2": "3,907.00",
          "chgp": "-22.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "43,617.00",
          "val2": "74,896.00",
          "chgp": "-41.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "144.70%",
          "val2": "135.70%",
          "chgp": "0.90%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 11.87% vs 19.25% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 474.57% vs 197.72% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,139,245.00",
          "val2": "1,912,323.00",
          "chgp": "11.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "614,292.00",
          "val2": "454,804.00",
          "chgp": "35.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10,776.00",
          "val2": "14,349.00",
          "chgp": "-24.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-48,930.00",
          "val2": "-190,558.00",
          "chgp": "74.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "291,575.00",
          "val2": "50,747.00",
          "chgp": "474.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "196.20%",
          "val2": "133.70%",
          "chgp": "6.25%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

537,925.00

459,294.00

17.12%

Operating Profit (PBDIT) excl Other Income

128,212.00

110,013.00

16.54%

Interest

3,035.00

3,907.00

-22.32%

Exceptional Items

0.00

0.00

Consolidate Net Profit

43,617.00

74,896.00

-41.76%

Operating Profit Margin (Excl OI)

144.70%

135.70%

0.90%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 17.12% vs 10.78% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -41.76% vs 325.06% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

2,139,245.00

1,912,323.00

11.87%

Operating Profit (PBDIT) excl Other Income

614,292.00

454,804.00

35.07%

Interest

10,776.00

14,349.00

-24.90%

Exceptional Items

-48,930.00

-190,558.00

74.32%

Consolidate Net Profit

291,575.00

50,747.00

474.57%

Operating Profit Margin (Excl OI)

196.20%

133.70%

6.25%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 11.87% vs 19.25% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 474.57% vs 197.72% in Mar 2025

All Annual Results